Organon & Co (OGN)
20.51
+0.14
(+0.69%)
USD |
NYSE |
May 09, 16:00
20.51
0.00 (0.00%)
After-Hours: 20:00
Organon PE Ratio: 5.015 for May 9, 2024
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| May 09, 2024 | 5.015 |
| May 08, 2024 | 4.980 |
| May 07, 2024 | 4.988 |
| May 06, 2024 | 5.056 |
| May 03, 2024 | 4.795 |
| May 02, 2024 | 4.768 |
| May 01, 2024 | 4.604 |
| April 30, 2024 | 4.550 |
| April 29, 2024 | 4.621 |
| April 26, 2024 | 4.536 |
| April 25, 2024 | 4.504 |
| April 24, 2024 | 4.575 |
| April 23, 2024 | 4.528 |
| April 22, 2024 | 4.401 |
| April 19, 2024 | 4.357 |
| April 18, 2024 | 4.367 |
| April 17, 2024 | 4.369 |
| April 16, 2024 | 4.350 |
| April 15, 2024 | 4.330 |
| April 12, 2024 | 4.266 |
| April 11, 2024 | 4.469 |
| April 10, 2024 | 4.440 |
| April 09, 2024 | 4.501 |
| April 08, 2024 | 4.440 |
| April 05, 2024 | 4.367 |
| Date | Value |
|---|---|
| April 04, 2024 | 4.369 |
| April 03, 2024 | 4.379 |
| April 02, 2024 | 4.433 |
| April 01, 2024 | 4.523 |
| March 31, 2024 | 4.597 |
| March 28, 2024 | 4.70 |
| March 27, 2024 | 4.612 |
| March 26, 2024 | 4.53 |
| March 25, 2024 | 4.455 |
| March 22, 2024 | 4.445 |
| March 21, 2024 | 4.575 |
| March 20, 2024 | 4.538 |
| March 19, 2024 | 4.485 |
| March 18, 2024 | 4.452 |
| March 15, 2024 | 4.57 |
| March 14, 2024 | 4.59 |
| March 13, 2024 | 4.638 |
| March 12, 2024 | 4.568 |
| March 11, 2024 | 4.585 |
| March 08, 2024 | 4.612 |
| March 07, 2024 | 4.558 |
| March 06, 2024 | 4.492 |
| March 05, 2024 | 4.438 |
| March 04, 2024 | 4.348 |
| March 01, 2024 | 4.39 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
3.445
Minimum
Jan 04 2024
8.936
Maximum
Jan 17 2023
6.135
Average
6.298
Median
PE Ratio Benchmarks
| Amgen Inc | 44.73 |
| Merck & Co Inc | 144.70 |
| Pfizer Inc | -- |
| Alnylam Pharmaceuticals Inc | -- |
| Moderna Inc | -- |
PE Ratio Related Metrics
| PS Ratio | 0.8299 |
| PEG Ratio | 0.1252 |
| Price to Book Value | 109.89 |
| Price to Free Cash Flow | 11.50 |
| Price | 20.51 |
| Earnings Yield | 19.94% |
| Market Cap | 5.276B |
| PEGY Ratio | 0.1101 |
| Operating PE Ratio | 3.910 |
| Normalized PE Ratio | 4.544 |